MR imaging of the globe and optic nerve

Magnetic Resonance Imaging Clinics of North America

Volumn 10, Issue 4, 2002, Pages 663-678

  Belden, Clifford J ^a  

^a BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; MEDICAL SPECIALIST; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE;

EYE; EYE DISEASES; EYE NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; OPTIC NERVE; OPTIC NERVE DISEASES;

EID: 0036867002     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1064-9689(02)00018-1     Document Type: Article

References (23)

1. Mahima Y, Oshitari K, Imamura Y, et al. Highresolution magnetic resonance imaging of the intraorbital optic nerve and subarachnoid space in patients with papilledema and optic atrophy. Arch Ophthalmol 1996;114:1197-203.
2. Parravano JG, Toledo A, Kucharczyk W. Dimensions of the optic nerves, chiasm, and tracts: MR quantitative comparison between patients with optic atrophy and normals. J Comput Assist Tomogr 1993;17(5):688-90.
3. Eggenberger ER. Inflammatory optic neuropathies. Ophthalmol Clin North Am 2001;14:73-82.
4. The Optic Neuritis Study Group. The clinical profile of optic neuritis. The experience of the optic neuritis treatment trial. Arch Ophthalmol 1991;109:1673-7.
5. The Optic Neuritis Study Group. The 5-year risk of MS after optic neuritis: Experience of the optic neuritis treatment trial. Neurology 1997;49:1404-13.
6. Jacobs LD, Beck RW, Simon JH, et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 2000;343:898-904.
7. Jackson A, Sheppard S, Laitt RD, Kassner A, Moriarty D. Optic neuritis: MR imaging with combined fat- and water-suppression techniques. Radiology 1998;206:57-63.
8. Gass A, Moseley IF, Barker GJ, et al. Lesion discrimination in optic neuritis using high-resolution fat-suppressed fast spin-echo MR imaging. Neuroradiology 1996;38:317-21.
9. Cornblath WT, Quint DJ. MR imaging of optic nerve enlargement in optic neuritis. Neurology 1997;48:821-5.
10. Purvin V, Kawasaki A, Jacobson DM. Optic perineuritis: Clinical and radiographic features. Arch Ophthalmol 2001;119:1299-306.
11. Arnold AC. Ischemic optic neuropathies. Ophthalmol Clin North Am 2001;14:83-98.
12. Balcer LJ. Anatomic review and topographic diagnosis. Ophthalmol Clin North Am 2001;14:1-21.
13. Van Stavern GP, Newman NJ. Optic neuropathies: An overview. Ophthalmol Clin North Am 2001;14:61-71.
14. Dutton JJ. Gliomas of the anterior visual pathways. Surv Ophthalmol 1994;38:427-52.
15. Lee AG, Dutton JJ. A practice pathway for the management of gliomas of the anterior visual pathway: An update and an evidence-based approach. Neuroophthalmology 1999;22:139-55.
16. Parsa CF, Hoyt CS, Lesser RL, et al. Spontaneous regression of optic gliomas: Thirteen cases documented by serial neuroimaging. Arch Ophthalmol 2001;119:516-29.
17. Dutton JJ. Optic nerve sheath meningiomas. Surv Ophthalmol 1992;37:167-83.
18. Smirniotopoulos JG, Bargallo N, Maffee MF. Differential diagnosis of leukocoria: Radiologicpathologic correlation. Radiographics 1994;14:1059-79
19. Wycliffe ND, Mafee MF. Magnetic resonance imaging in ocular pathology. Top Magn Reson Imaging 1999;10:384-400.
20. DePotter P, Shields CL, Shields JA, Flanders AE. The role of magnetic resonance imaging in children with intraocular tumors and simulating lesions. Ophthalmology 1996;103:1774-83.
21. Edward DP, Maffee MF, Garcia-Valenzuela E, Weiss RA. Coats' disease and persistent hyperplastic primary vitreous: Role of MR Imaging and CT. Radiol Clin North Am 1998;36:1119-31.
22. Galluzzi P, Venturi C, Cerase A, et al. Coats disease: Smaller volume of the affected globe. Radiology 2001;221:64-9.
23. Howard GM, Ellsworth RM. Differential diagnosis of retinoblastoma: A statistical survey of 500 children. Am J Ophthalmol 1965;60:610-8.